154 related articles for article (PubMed ID: 31116141)
1. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
[TBL] [Abstract][Full Text] [Related]
2. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
Haffner MC; Laimer J; Chaux A; Schäfer G; Obrist P; Brunner A; Kronberger IE; Laimer K; Gurel B; Koller JB; Seifarth C; Zelger B; Klocker H; Rasse M; Doppler W; Bander NH
Mod Pathol; 2012 Aug; 25(8):1079-85. PubMed ID: 22460809
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
5. Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving
Seifert R; Seitzer K; Herrmann K; Kessel K; Schäfers M; Kleesiek J; Weckesser M; Boegemann M; Rahbar K
Theranostics; 2020; 10(17):7812-7820. PubMed ID: 32685021
[No Abstract] [Full Text] [Related]
6. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Samplaski MK; Heston W; Elson P; Magi-Galluzzi C; Hansel DE
Mod Pathol; 2011 Nov; 24(11):1521-9. PubMed ID: 21725290
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.
Zeng C; Ke ZF; Yang Z; Wang Z; Yang SC; Luo CQ; Wang LT
Med Oncol; 2012 Sep; 29(3):2234-9. PubMed ID: 22009216
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
11. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
Huang GW; Ding X; Chen SL; Zeng L
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH
Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen as a marker of pancreatic cancer cells.
Ren H; Zhang H; Wang X; Liu J; Yuan Z; Hao J
Med Oncol; 2014 Mar; 31(3):857. PubMed ID: 24477651
[TBL] [Abstract][Full Text] [Related]
15. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
[TBL] [Abstract][Full Text] [Related]
16. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
Jin Y; Liang ZY; Zhou WX; Zhou L
J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
[TBL] [Abstract][Full Text] [Related]
17. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
18. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
Zhu JY; Sun QK; Wang W; Jia WD
Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
[TBL] [Abstract][Full Text] [Related]
20. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
